Comparison of bioluminescent kinase assays using substrate depletion and product formation.
暂无分享,去创建一个
James Inglese | Min Shen | Cordelle Tanega | Ryan MacArthur | Bryan T Mott | D. Auld | James Inglese | M. Shen | Craig J. Thomas | B. Mott | R. Macarthur | Craig J Thomas | Douglas S Auld | C. Tanega
[1] F. Fan,et al. Bioluminescent assays for high-throughput screening. , 2007, Assay and drug development technologies.
[2] R. Campbell,et al. Development of a Transcreener™ Kinase Assay for Protein Kinase A and Demonstration of Concordance of Data with a Filter-Binding Assay Format , 2007, Journal of biomolecular screening.
[3] Adam Yasgar,et al. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[4] T. Ching. A sensitive and simple assay of starch synthase activity with pyruvate kinase and luciferase. , 1982, Analytical biochemistry.
[5] Kim E. Garbison,et al. The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies , 2006, Journal of biomolecular screening.
[6] J Fraser Glickman,et al. Scintillation proximity assays in high-throughput screening. , 2008, Assay and drug development technologies.
[7] Peter J. Coassin,et al. Piezo- and solenoid valve-based liquid dispensing for miniaturized assays. , 2005, Assay and drug development technologies.
[8] R. Eglen,et al. A Generic, Homogenous Method for Measuring Kinase and Inhibitor Activity via Adenosine 5′-Diphosphate Accumulation , 2006, Journal of biomolecular screening.
[9] Christopher P Austin,et al. Monitoring Compound Integrity With Cytochrome P450 Assays and qHTS , 2009, Journal of biomolecular screening.
[10] Christopher P Austin,et al. High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.
[11] J. Sportsman,et al. A Homogeneous Fluorescence Polarization Assay Adaptable for a Range of Protein Serine/Threonine and Tyrosine Kinases , 2003, Journal of biomolecular screening.
[12] L. Makings,et al. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. , 2002, Assay and drug development technologies.
[13] P. Broad,et al. Identification of kinase inhibitors by an ATP depletion method. , 2004, Assay and drug development technologies.
[14] Christopher P Austin,et al. Characterization of chemical libraries for luciferase inhibitory activity. , 2008, Journal of medicinal chemistry.
[15] J. Hornberg,et al. Characterization and optimization of a red-shifted fluorescence polarization ADP detection assay. , 2009, Assay and drug development technologies.
[16] W. Jenkins. The pyruvate kinase-coupled assay for ATPases: a critical analysis. , 1991, Analytical biochemistry.
[17] I. H. Segel. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .
[18] Yue Yuan,et al. Determining Appropriate Substrate Conversion for Enzymatic Assays in High-Throughput Screening , 2003, Journal of biomolecular screening.
[19] Christopher P Austin,et al. Identification of pregnane X receptor ligands using time-resolved fluorescence resonance energy transfer and quantitative high-throughput screening. , 2009, Assay and drug development technologies.
[20] A. Bridges,et al. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. , 1994, Science.
[21] Sam Michael,et al. Compound Management for Quantitative High-Throughput Screening , 2008, JALA.
[22] J. Sportsman,et al. Immobilized metal ion affinity-based fluorescence polarization (IMAP): advances in kinase screening. , 2004, Assay and drug development technologies.
[23] Hiroshi Kimura,et al. Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks* , 2004, Journal of Biological Chemistry.
[24] Christopher P Austin,et al. A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution. , 2009, Journal of medicinal chemistry.
[25] Yanli Wang,et al. PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .
[26] T. Turek-Etienne,et al. Development of a fluorescence polarization AKT serine/threonine kinase assay using an immobilized metal ion affinity-based technology. , 2003, Assay and drug development technologies.
[27] G. Zaman,et al. High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. , 2003, Assay and drug development technologies.
[28] T. Spicer,et al. Comparison of Miniaturized Time-Resolved Fluorescence Resonance Energy Transfer and Enzyme-Coupled Luciferase High-Throughput Screening Assays to Discover Inhibitors of Rho-Kinase II (ROCK-II) , 2008, Journal of biomolecular screening.
[29] T. Misteli,et al. Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk). , 2009, Bioorganic & medicinal chemistry letters.
[30] R. Eglen,et al. The current status of drug discovery against the human kinome. , 2009, Assay and drug development technologies.
[31] P. Cleveland,et al. Nanoliter dispensing for uHTS using pin tools. , 2005, Assay and drug development technologies.
[32] H. Cottam,et al. Substituted isoquinolines and quinazolines as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor alpha. , 1999, Journal of medicinal chemistry.
[33] D. Auld,et al. Evaluation of compound interference in immobilized metal ion affinity-based fluorescence polarization detection with a four million member compound collection. , 2003, Assay and drug development technologies.